CRSP

CRISPR THERAPEUTICS AG

Healthcare | Mid Cap

-$1.16

EPS Forecast

$4.95

Revenue Forecast

Announcing earnings for the quarter ending 2025-03-31 soon
BLUEBluebird Bio IncDNLIDenali Therapeutics IncREPLReplimune Group IncRGENRepligen CorpTECHBio-techne CorpHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncNVAXNovavax IncMRNAModerna Inc